These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27453320)

  • 1. Age-specific genetic and antigenic variations of influenza A viruses in Hong Kong, 2013-2014.
    Cao P; Wong CM; Chan KH; Wang X; Chan KP; Peiris JS; Poon LL; Yang L
    Sci Rep; 2016 Jul; 6():30260. PubMed ID: 27453320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the 2009 H1N1 Pandemic on Age-Specific Epidemic Curves of Other Respiratory Viruses: A Comparison of Pre-Pandemic, Pandemic and Post-Pandemic Periods in a Subtropical City.
    Yang L; Chan KH; Suen LK; Chan KP; Wang X; Cao P; He D; Peiris JS; Wong CM
    PLoS One; 2015; 10(4):e0125447. PubMed ID: 25928217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic and genetic variation in the hemagglutinins of H1N1 and H3N2 human influenza a viruses in the Shanghai area from 2005 to 2008.
    Ren XW; Ju LW; Yang JX; Lv XH; Jiang LF; Zhao NQ; Jiang QW
    J Med Virol; 2011 Jul; 83(7):1113-20. PubMed ID: 21520138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic characterization of influenza viruses from influenza-related hospital admissions in the St. Petersburg and Valencia sites of the Global Influenza Hospital Surveillance Network during the 2013/14 influenza season.
    López-Labrador FX; Natividad-Sancho A; Pisareva M; Komissarov A; Salvatierra K; Fadeev A; Moya A; Grudinin M; Díez-Domingo J; Afanasieva O; Konovalova N; Sominina A; Puig-Barberà J
    J Clin Virol; 2016 Nov; 84():32-38. PubMed ID: 27690141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating influenza antigenic dynamics with molecular evolution.
    Bedford T; Suchard MA; Lemey P; Dudas G; Gregory V; Hay AJ; McCauley JW; Russell CA; Smith DJ; Rambaut A
    Elife; 2014; 3():e01914. PubMed ID: 24497547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The spread and biological properties of epidemic influenza viruses A and B strains circulating in the 2006-2007 season in Russia].
    Ivanova VT; Kurochkina IaE; Burtseva EI; Oskerko TA; Trushakova SV; Shevchenko ES; Cherkasov EG; Shchelkanov MIu; Matiushina RO; Kolobukhina LV; Feodoritova EL; Slepushkin AN
    Vopr Virusol; 2008; 53(5):19-23. PubMed ID: 19069788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the antigenicity and HA1 gene characteristics of influenza A viruses during 2004-2008 year in China].
    Zhang Y; Zhao X; Huang WJ; Guo JF; Wei HJ; Cheng YH; Li XW; Li XY; Guo YJ; Shu YL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Dec; 23(6):405-8. PubMed ID: 20718339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing Antigenic Drift of Seasonal Influenza A(H3N2) and A(H1N1)pdm09 Viruses.
    Tewawong N; Prachayangprecha S; Vichiwattana P; Korkong S; Klinfueng S; Vongpunsawad S; Thongmee T; Theamboonlers A; Poovorawan Y
    PLoS One; 2015; 10(10):e0139958. PubMed ID: 26440103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology and evolution of A(H1N1)pdm09 and H3N2 virus during winter 2012-2013 in Beijing, China.
    Fang Q; Gao Y; Chen M; Guo X; Yang X; Yang X; Wei L
    Infect Genet Evol; 2014 Aug; 26():228-40. PubMed ID: 24911284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial.
    Hung IF; Zhang AJ; To KK; Chan JF; Li P; Wong TL; Zhang R; Chan TC; Chan BC; Wai HH; Chan LW; Fong HP; Hui RK; Kong KL; Leung AC; Ngan AH; Tsang LW; Yeung AP; Yiu GC; Yung W; Lau JY; Chen H; Chan KH; Yuen KY
    Lancet Infect Dis; 2016 Feb; 16(2):209-18. PubMed ID: 26559482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic variation of H1N1, H1N2 and H3N2 swine influenza viruses in Japan and Vietnam.
    Takemae N; Nguyen T; Ngo LT; Hiromoto Y; Uchida Y; Pham VP; Kageyama T; Kasuo S; Shimada S; Yamashita Y; Goto K; Kubo H; Le VT; Van Vo H; Do HT; Nguyen DH; Hayashi T; Matsuu A; Saito T
    Arch Virol; 2013 Apr; 158(4):859-76. PubMed ID: 23435952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of the hemagglutinin expressed by human influenza A(H1N1)pdm09 and A(H3N2) viruses circulating between 2008-2009 and 2013-2014 in Germany.
    Wedde M; Biere B; Wolff T; Schweiger B
    Int J Med Microbiol; 2015 Oct; 305(7):762-75. PubMed ID: 26416089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza A/H1N1pdm virus in Russian Asia in 2009-2010.
    Ilyicheva T; Susloparov I; Durymanov A; Romanovskaya A; Sharshov K; Kurskaya O; Ignashkina M; Shestopalov A
    Infect Genet Evol; 2011 Dec; 11(8):2107-12. PubMed ID: 21600305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
    J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virologically confirmed population-based burden of hospitalization caused by influenza A and B among children in Hong Kong.
    Chiu SS; Chan KH; Chen H; Young BW; Lim W; Wong WH; Lau YL; Peiris JS
    Clin Infect Dis; 2009 Oct; 49(7):1016-21. PubMed ID: 19722912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.
    Lytras T; Kossyvakis A; Melidou A; Andreopoulou A; Exindari M; Gioula G; Kalliaropoulos A; Tryfinopoulou K; Pogka V; Spala G; Malisiovas N; Mentis A
    J Med Virol; 2016 Nov; 88(11):1896-904. PubMed ID: 27088266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.
    Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R
    Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
    Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
    J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.
    Skowronski DM; Janjua NZ; De Serres G; Winter AL; Dickinson JA; Gardy JL; Gubbay J; Fonseca K; Charest H; Crowcroft NS; Fradet MD; Bastien N; Li Y; Krajden M; Sabaiduc S; Petric M
    Clin Infect Dis; 2012 Aug; 55(3):332-42. PubMed ID: 22539661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age and Sex Differences in Rates of Influenza-Associated Hospitalizations in Hong Kong.
    Wang XL; Yang L; Chan KH; Chan KP; Cao PH; Lau EH; Peiris JS; Wong CM
    Am J Epidemiol; 2015 Aug; 182(4):335-44. PubMed ID: 26219977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.